daunorubicin has been researched along with Carcinoma, Anaplastic in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (50.00) | 18.7374 |
| 1990's | 7 (26.92) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 1 (3.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hofman, J; Malcekova, B; Novotna, E; Skarka, A; Wsol, V | 1 |
| Chorvath, B; Duraj, J; Hunakova, L; Jakubikova, J; Sedlak, J | 1 |
| Lage, H; Nieth, C; Priebsch, A; Stege, A | 1 |
| Akimova, AIa; Chissov, VI; Rusakov, IG; Shchitkov, KG | 1 |
| Bogush, T; Robert, J; Shubina, I; Smirnova, G; Syrkin, A | 1 |
| De Bruijn, EA; Eggermont, A; Gheuens, E; Van Bockstaele, D; van de Vrie, W; van der Heyden, S; Van Oosterom, A | 1 |
| Belliot, SO; Crommelin, DJ; Haisma, HJ; Smit, RH; Storm, G; Vingerhoeds, MH | 1 |
| Krejovic, B; Pendjer, I; Vucicevic, S | 1 |
| Feller, N; Hoekman, K; Kuiper, CM; Linn, SC; Pinedo, HM; Popp-Snijders, C; Verheul, HM; Wolthers, BG | 1 |
| Hellström, I; Hellström, KE; Senter, PD | 1 |
| Blay, JY; Boulez, J; Fléchon, A; Lombard-Bohas, C; Scoazec, JY | 1 |
| Chauvier, D; Manfait, M; Morjani, H | 1 |
| Burgess, MA; Byers, R; Rentschler, R | 1 |
| Coley, HM; Twentyman, PR; Workman, P | 1 |
| Amadori, D; Dollbaum, C; Hackett, AJ; Hiller, A; Lippman, M; Mayall, B; Smith, HS; Swain, S; Volpi, A; Zoli, W | 1 |
| Bonatskaia, LV; Nikolaev, VG; Plotnikov, VM | 1 |
| Boschetti, E; Daussin, F; Delmotte, F; Monsigny, M | 1 |
| Bruzzone, M; Chiara, S; Conte, PF; Falcone, A; Graziani, G; Rosso, R | 1 |
| Casper, ES; Currie, VE; Hakes, TB; Kaufman, RJ; Raymond, V | 1 |
| Boule, D; Fourcade, A; Tapiéro, H; Trincal, G | 1 |
| Cardarelli, CO; Cornwell, MM; Gottesman, MM; Pastan, I; Willingham, MC | 1 |
| Begleiter, A; Glazer, RI; Johnston, JB | 1 |
| Chauvergne, J | 1 |
| Bello, LJ; Brinker, JM; Madore, HP | 1 |
| Arcamone, F; Franceschi, G; Minghetti, A; Penco, S; Redaelli, S | 1 |
1 review(s) available for daunorubicin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Development and activities of the BR96-doxorubicin immunoconjugate.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antigens, Neoplasm; Carcinoma; Clinical Trials, Phase I as Topic; Colonic Neoplasms; Daunorubicin; Digestive System; Doxorubicin; Drug Design; Gastrointestinal Diseases; Humans; Immunotoxins; Lewis Blood Group Antigens; Mice; Mice, Nude; Neoplasms; Neoplasms, Experimental; Organ Specificity; Rats; Rats, Inbred BN; Rats, Nude; Treatment Failure; Xenograft Model Antitumor Assays | 2001 |
25 other study(ies) available for daunorubicin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Carcinoma; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Flavanones; Humans; Hydroxyprostaglandin Dehydrogenases; Idarubicin; Kinetics; Neoplasm Proteins; Oxidation-Reduction; Recombinant Proteins | 2014 |
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluoresceins; Fluorescent Dyes; HL-60 Cells; Humans; Isoquinolines; Leukemia, Myeloid; Ligands; Mitochondrial Proteins; Ovarian Neoplasms; Receptors, GABA-A; Tumor Cells, Cultured | 2002 |
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).
Topics: Carcinoma; Daunorubicin; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Pancreatic Neoplasms; Phenotype; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Stomach Neoplasms; Tumor Cells, Cultured | 2003 |
[Effect of a mixture of carminomycin and cyanoacrylates on experimental tumor growth].
Topics: Animals; Carcinoma; Carubicin; Cyanoacrylates; Daunorubicin; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Male; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Preliminary results of a phase II trial on solid tumors of detorubicin, a new anthracyclin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasms; Uterine Neoplasms | 1980 |
Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.
Topics: Animals; Binding Sites; Bisbenzimidazole; Carcinoma; Cell Division; Cyanoacrylates; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Glioblastoma; Humans; Leukemia, Erythroblastic, Acute; Ovarian Neoplasms; Polyglutamic Acid; Polymers; Rats; Tumor Cells, Cultured | 1995 |
5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expression.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Carrier Proteins; Colonic Neoplasms; Daunorubicin; Drug Resistance; Flow Cytometry; Floxuridine; Membrane Glycoproteins; Prodrugs; Rats; Tumor Cells, Cultured | 1994 |
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Binding Sites; Carcinoma; Cross-Linking Reagents; Daunorubicin; Drug Carriers; Female; Glucuronates; Glucuronidase; Humans; Imidoesters; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Prodrugs; Succinimides; Sulfides; Tumor Cells, Cultured | 1996 |
A comparative study of undifferentiated nasopharyngeal carcinoma treated with radiotherapy or combined treatment with zorubicin-cisplatin and radiotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Daunorubicin; Drug Administration Schedule; Female; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Tumor Virus Infections | 1997 |
A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.
Topics: Adrenal Cortex Neoplasms; Adult; Androgens; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Genes, p53; Glucocorticoids; Humans; Male; Mineralocorticoids; Mitotane; Neoplasm Proteins; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles; Vincristine | 1997 |
Complete response of an HIV negative gastric Kaposi's sarcoma (KS) patient with peritoneal carcinomatosis by liposomal daunorubicin treatment.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; HIV Seronegativity; Humans; Liposomes; Male; Peritoneal Neoplasms; Sarcoma, Kaposi; Stomach Neoplasms | 2001 |
Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Leukemia, Myeloid; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Polymerase Chain Reaction; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured | 2002 |
Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of M. D. Anderson Hospital experience.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma; Carcinoma, Adenoid Cystic; Child; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Parotid Neoplasms; Recurrence; Salivary Gland Neoplasms; Submandibular Gland | 1977 |
Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma; Daunorubicin; Drug Resistance; Humans; Lung Neoplasms; Membrane Glycoproteins; Tumor Cells, Cultured; Verapamil | 1991 |
Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Survival; Cisplatin; Daunorubicin; Doxorubicin; Epirubicin; Humans; In Vitro Techniques; Prognosis; Tumor Cells, Cultured; Vinblastine | 1990 |
[Decrease in the blood toxicity of antitumor preparations during enterosorption].
Topics: Adsorption; Animals; Blood; Carcinoma; Carubicin; Charcoal; Cyclophosphamide; Daunorubicin; Hematopoiesis; Intestinal Absorption; Leukemia, Erythroblastic, Acute; Methotrexate; Neoplasm Transplantation; Rats | 1989 |
p-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. A new drug acid-labile arm-carrier conjugate.
Topics: Acrylates; Aspartic Acid; Binding Sites; Carcinoma; Cell Survival; Daunorubicin; Hydrogen-Ion Concentration; Lung Neoplasms; Pharmaceutical Vehicles; Thiocarbamates; Tumor Cells, Cultured | 1988 |
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Drug Resistance; Female; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms | 1987 |
Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Carcinoma; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Middle Aged | 1987 |
[Role of cell pharmacokinetics in the modulation of modalities in the administration of anthracyclines].
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Doxorubicin; Drug Resistance; Friend murine leukemia virus; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Mice | 1987 |
Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
Topics: Biological Transport; Carcinoma; Cell Nucleus; Daunorubicin; Drug Resistance; Humans; KB Cells; Quinidine; Verapamil; Vinblastine; Vincristine | 1986 |
Effects of 3'-(4-morpholinyl)-3'-deaminodaunorubicin,3'- (4-methoxy-1-piperidinyl)-3'-deaminodaunorubicin and daunorubicin on nuclear and polysomal RNA synthesis in human colon carcinoma cells in vitro.
Topics: Antineoplastic Agents; Carcinoma; Cell Line; Cell Nucleus; Colonic Neoplasms; Daunorubicin; Humans; Polyribosomes; RNA, Neoplasm | 1986 |
[Trial of chemotherapy with a new antimitotic derivative].
Topics: Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Fibrosarcoma; Humans; Hydrazones; Kidney Neoplasms; Lung Neoplasms; Neoplasm Metastasis | 1973 |
Stabilization of heterogeneous nuclear RNA by intercalating drugs.
Topics: Acridines; Amines; Binding Sites; Carbon Isotopes; Carcinoma; Cell Line; Cycloheximide; Dactinomycin; Daunorubicin; Drug Stability; Ethidium; Humans; Kinetics; Mouth Neoplasms; Nucleic Acid Conformation; Nucleic Acid Denaturation; Phenanthridines; RNA, Neoplasm | 1973 |
Synthesis and biological evaluation of some 14-O-acyl derivatives of adriamycin.
Topics: Acylation; AKR murine leukemia virus; Animals; Carcinoma; Cells, Cultured; Daunorubicin; Doxorubicin; Embryo, Mammalian; Esters; Female; Fibroblasts; HeLa Cells; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Moloney murine leukemia virus; Neoplasm Transplantation; Sarcoma 180; Sarcoma, Experimental | 1974 |